• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
71,947.55 -1,635.67
( -2.22%)
Global Indices
Nasdaq
45,242.12 54.47
(0.12%)
Dow Jones
6,365.58 -24.27
(-0.38%)
Hang Seng
51,264.29 -621.56
(-1.20%)
Nikkei 225
10,176.45 48.49
(0.48%)
Forex
USD-INR
94.53 0.44
(0.47%)
EUR-INR
108.77 0.13
(0.12%)
GBP-INR
125.32 -0.25
(-0.20%)
JPY-INR
0.59 0.00
(-0.02%)

EQUITY - MARKET SCREENER

Nephro Care India Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
92991
INE0SUN01013
32.4415882
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NEPHROCARE
29.74
85.32
EPS(TTM)
Face Value()
Div & Yield %
1.74
10
0
 

coffee day enterprises ltd
MCX soars past Rs 10,000 mark amid sustained rally
Nov 26,2025
The stock touched a fresh lifetime high of Rs 10,250 intraday. MCX has gained 5.82% over the past three sessions, rising 13.46% in one month and 33.05% in three months.

The stock has delivered a spectacular run in 2025, soaring 132.15% in just eight months from its 52-week low of Rs 4,408 hit on 11 March.

The rally has been amplified by a surge in precious metals and other commodities traded on the platform, driving heightened investor interest. Adding to the momentum, a domestic brokerage recently initiated coverage with a target price of Rs 12,500, implying nearly 22.08% upside from current levels. A foreign brokerage has also lifted its target price to Rs 12,000 from Rs 10,000 while retaining its 'Buy' rating.

MCX is India's largest commodity derivatives exchange with around 98% market share in commodity futures. It offers trading in a diverse range of commodities, spanning multiple segments including bullion, energy, metals and agri commodities, as well as sectoral commodity indices.

It reported 29% rise in consolidated net profit to Rs 197.47 crore on a 31% increase in revenue to Rs 374.23 crore in Q2 FY26 over Q2 FY25.